Page 10 - Read Online
P. 10

58         Viral hepatitis as a risk factor for the development of hepatocellular carcinoma
                        Saleh A. Alqahtani, Massimo Colombo
                        Hepatoma Res 2020;6:58  http://dx.doi.org/10.20517/2394-5079.2020.49


           59         Alternative approach of hepatocellular carcinoma surveillance: abbreviated MRI
                        Ryan L. Brunsing, Kathryn J. Fowler, Takeshi Yokoo, Guilherme Moura Cunha, Claude B. Sirlin, Robert M.
                        Marks
                        Hepatoma Res 2020;6:59  http://dx.doi.org/10.20517/2394-5079.2020.50

           60         Comparison and analysis of the efficacy of drug therapy for liver cancer
                        Philippe Merle, Miroslava Subic
                        Hepatoma Res 2020;6:60  http://dx.doi.org/10.20517/2394-5079.2020.52


           61         Detection of circulating tumor cells in hepatocellular carcinoma: applications in diagnosis, prognosis
                        prediction and personalized treatment
                        Peng-Xiang Wang, Jian-Wen Cheng, Xin-Rong Yang
                        Hepatoma Res 2020;6:61  http://dx.doi.org/10.20517/2394-5079.2020.55


           62         Evaluation and impact of different biomarkers for early detection of hepatocellular carcinoma
                        Jan Best, Svenja Sydor, Lars P. Bechmann, Ali Canbay
                        Hepatoma Res 2020;6:62  http://dx.doi.org/10.20517/2394-5079.2020.56

           63         CT and MRI of the liver for hepatocellular carcinoma
                        Cynthia Santillan
                        Hepatoma Res 2020;6:63  http://dx.doi.org/10.20517/2394-5079.2020.60


           64         From nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease: is it time for a
                        change of terminology?
                        Giovanni Targher, Christopher D. Byrne
                        Hepatoma Res 2020;6:64  http://dx.doi.org/10.20517/2394-5079.2020.71


           65         Robotic-assisted laparoscopic liver resection in hepatocellular carcinoma
                        Kevin P. Labadie, James O. Park, Jonathan G. Sham
                        Hepatoma Res 2020;6:65  http://dx.doi.org/10.20517/2394-5079.2020.86

           66         Stereotactic body radiation therapy for primary liver tumors with adverse factors
                        Takuya Shimizuguchi, Jun Imamura, Simpei Hashimoto, Katsuyuki Karasawa
                        Hepatoma Res 2020;6:66  http://dx.doi.org/10.20517/2394-5079.2020.51

           67         Prognostic ability of inflammation-based markers in radioembolization for hepatocellular carcinoma
                        Grant Yoneoka, Kliment Bozhilov, Linda L. Wong
                        Hepatoma Res 2020;6:67  http://dx.doi.org/10.20517/2394-5079.2020.57
   5   6   7   8   9   10   11   12   13   14   15